Whites Need Not Apply: Non-White New Yorkers to Receive Priority For Scarce Monoclonal Antibody Treatment
Whites need not apply.
Non-white New Yorkers will receive priority for scarce monoclonal antibody treatments and Covid oral antiviral pills.
The New York State Department of Health this week published a memo warning they don’t have enough Paxlovid or Monoclonal Antibody Treatment so white people will be put at the back of the line.
The NYSDOH said Paxlovid and Molnupiravir are in “limited supply will require providers to prioritize treatment for patients at highest risk for severe COVID-19 until more product becomes available.”
The department said it will be prioritize people who have certain risk factors for severe disease.
One of the risk factors?
Race.
“Non-white race or Hispanic/Latino ethnicity should be considered a risk factor,
